1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Androgen deprivation therapy and side effects : Are GnRH antagonists safer?
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
(
- Contribution to journal › Article
- 2019
-
Mark
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer : The European Association of Urology Position in 2019
(
- Contribution to journal › Article
- 2017
-
Mark
Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy
(
- Contribution to journal › Article
-
Mark
Intermittent androgen deprivation therapy in patients with prostate cancer : Connecting the dots
(
- Contribution to journal › Article
- 2014
-
Mark
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Early Detection of Prostate Cancer: European Association of Urology Recommendation
(
- Contribution to journal › Article
- 2010
-
Mark
Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy
(
- Contribution to journal › Article